Safety and Socio-Economic Issues Raised by Modern Biotechnology by Xue, Dayuan & Tisdell, Clement A.
ISSN 1327-8231 
 




Working Paper No. 36 
 
 











  THE UNIVERSITY OF QUEENSLAND 
 ISSN 1327-8231 
WORKING PAPERS ON 







Working Paper No. 36 
 
 
Safety and Socio-Economic Issues 












© All rights reserved 
 
                                                        




























WORKING PAPERS IN THE SERIES, Economics, Ecology and the Environment are 
published by the School of Economics, University of Queensland, 4072, Australia, as 
follow up to the Australian Centre for International Agricultural Research Project 40 of 
which Professor Clem Tisdell was the Project Leader.  Views expressed in these working 
papers are those of their authors and not necessarily of any of the organisations 
associated with the Project.  They should not be reproduced in whole or in part without 
the written permission of the Project Leader.  It is planned to publish contributions to this 
series over the next few years. 
 
Research for ACIAR project 40, Economic Impact and Rural Adjustments to Nature 
Conservation (Biodiversity) Programmes:  A Case Study of Xishuangbanna Dai 
Autonomous Prefecture, Yunnan, China was sponsored by the Australian Centre for 
International Agricultural Research (ACIAR), GPO Box 1571, Canberra, ACT, 2601, 
Australia. 
 
The research for ACIAR project 40 has led in part, to the research being carried out in 
this current series. 
 
For more information write to Emeritus Professor Clem Tisdell, School of Economics, 
University of Queensland, Brisbane 4072, Australia.  
 
 
   
  Safety and Socio-Economic Issues Raised by Modern Biotechnology 
 
Dayuan XUE and  Clem TISDELL 





Modern new biotechnology has the potential to provide major economic and other 
benefits, but at the same time it poses potential hazards for human health, the 
environment, the ‘natural’ biological order and can have adverse socio-economic 
consequences.  The application of such technology frequently violates traditional 
ethical, moral and religious values.  This paper after outlining possible benefits of 
modern new biotechnologies, discusses the type of biosafety risks which they pose, 
their possible adverse consequences for the sustainability of biodiversity and 
agriculture and their potential impacts on socioeconomic welfare and traditional 
cultures.  Particular concern is expressed about the possible consequences of such 
technologies for developing countries and the practice in some developed countries of 
issuing patents conferring very broad rights over the use of genetically engineered 
material.  Because these rights are so broad in some cases they have the potential to 
establish powerful multinational monopolies in the hands of private companies.   
Global debate about these issues suggest that more emphasis should be given globally 
to the socio-economic consequences of such technology than in the past.  The need 
for this is highlighted by the North-South divide.  Developing countries lag 
considerably in this new technological field, are placed in a dependant position and 
have weak institutional structures to control the application of such technology. 
 
Keywords:  biotechnology, socio-economic policy, genetic engineering, biodiversity, 
biosafety, patents 
 Safety and Socio-Economic Issues Raised by Modern Biotechnology 
 
Introduction:  
Biotechnology is a modern advanced technology based scientific fields such as on 
molecular biology, biochemistry, cell biology. It adopts many new techniques such as 
cell and tissue cultivation, cell fusion, gene recombination, microbal fermentation, so 
as to duplicate and recombine the organisms at the level of cell, chromosome, and 
gene, and create the best state of organisms according to human desires, and to 
produce new products and breed new fine varieties with novel traits of high 
productivity and stress resistance. Modern biotechnology is composed of four 
technological systems. They are genetic engineering, cell engineering, enzyme 
engineering and fermentation engineering, of which genetic engineering and cell 
engineering are the most recent advanced biotechnologies. 
 
Modern biotechnology can not only produce great social and economic benefits, but 
can also do harm to human health, environment, and result in many socioeconomic 
problems, such as destroying original social and economic pattern, posing threats to 
biodiversity and traditional crop varieties, injuring country’s or a community’s 
socioeconomic welfare, violating traditional ethical, moral and religious value. In 
order to enable biotechnology contribute major benefits to human beings at and to so 
safety, international society has paid great attention to the biosafety of living modified 
organisms (LMOs) produced by biotechnology. 
 
1. Social and economic benefits of modern biotechnology  
Biotechnologies are being used widely in such fields as medicine and hygiene, 
agriculture, forestry, raising, fisheries, energy and chemical industries, metallurgical 
and mining industries, food and light industries, environmental protection. Modern 
biotechnology has gradually demonstrated its huge potential contribution to 
productivity, though it has a short history of only tens of years so far. Modern 
biotechnology will become powerful means to reduce the world’s constraints in the 
fields of food, health, energy, resources and environment. The development and 
application of modern biotechnology will, over a long period of time, affect human 
beings and society deeply. Biotechnological industries are likely to become the 
leading industries in the 21st century. For example, crop varieties, produced by 
1 biotechnology, with novel traits of high productivity and stress resistance (aridity, 
coldness, high salt, etc) are expected not only to increase grain productivity, but also 
decrease the use of agricultural chemicals (such as pesticide, herbicide and fertilizer), 
which will be beneficial to environment. In the respect of medicine and hygiene, 
many drugs such as DNA vaccines, protein engineering medicine, monoclonal 
antibodies, antisense RNA drugs have been developed by biotechnology. Transgenic 
animals and plants producing some kinds of medicines (such as vaccines and 
hormone) may help to reduce illness in the process of everyday diet. Human Genome 
Project (HGP) and the research into some disease genes will discover the genetic 
reasons for some illnesses. Environmental pollution is getting worse at present, but 
biological transformation reactors created by biotechnology promise to absorb 
pollutants or wastes and decompose them into materials of low or no toxicity. 
 
Therefore, in the present society characterized by knowledge-intensive industries, 
countries all over the world, especially the industrialized countries, take 
biotechnology seriously. Large quantities of manpower and financial resources are 
allocated R & D of biotechnology. Relevant development strategies and policies are 
drawn up and support mechanisms created to stimulate the development of 
biotechnology.  
  
2  Biosafety issues of modern biotechnology  
Inappropriate application of biotechnology can result in many risks/hazards, just as 
other advanced technologies such as nuclear technology. Has done. For examples, the 
new genes in crop produced by genetic engineering can result in allergic reactions. 
Organism fed with genetically manipulated food for a long period of time may 
develop fatal diseases such as cancers. Being given the traits of pest-resistance, 
herbicide-resistance or stress-resistance, transgenic plants may escape from 
agricultural cultivation systems to evolve into vicious weeds. The resistance genes in 
transgenic plants may also be transferred to their wild weedy relatives, and the latter’s 
fitness might be improved to become “super” weeds which will make them more 
difficult to control. Large-scale environmental releases of transgenic pest-resistance 
crops will create huge selection pressures to accelerate the resistance of target pests. 
The foreign virus genes inserted and the proteins coded within transgenic virus-
resistance plants may recombine with genetic materials of other viruses and proteins 
2 to form new types of viruses with higher toxicity. Being not able to kill the target 
pests and pathogens selectively, the transgenic pest-and-disease resistance crops may 
poison other organisms simultaneously. Moreover, the pest-and-pathogen-killing 
material in transgenic plants not only can influence the target organisms, but also may 
have adverse effects through food chains on other organisms, which include beneficial 
insects, birds, and mammals and microbes (Andersson, et al. 1992). What is more, 
many biotechnological products are live organisms that can move automatically and 
reproduce themselves. Once these organisms are released into the environment are 
found harmful, it is probably going to be impossible to withdraw them, and the harm 
created by them may expand gradually and become more serious as time goes by.  
Therefore, environmental releases of transgenic plants in large-scale may damage the 
natural ecological balance over a very long period and deeply, therefore, the 
risks/hazards of modern biotechnology may be even greater  than that of nuclear 
techniques. 
 
Biosafety concerns have hindered the R & D of biotechnology. The public in many 
countries has expressed its feelings of dislike, abhorrence, even fear, about 
biotechnological products. This has been expressed by holding parades and 
demonstrations, destroying trial fields crops, forbidding the import of 
biotechnological products, and refusing to purchase biotechnological products 
(Williams, 1998). As a result, biosafety issues are high on the agenda of many 
countries and the international societies. Regulations or laws on biosafety have been 
formulated in many countries. The necessity or importance of settling biosafety issues 
have featured in many international documents and treaties such as Agenda 21 and 
The Convention on Biological Diversity. In addition, the document of International 
Technical Guidelines for Safety in Biotechnology was issued by United Nations 
Environment Program (UNEP) in 1996. Also an important decision to formulate an 
“International Biosafety Protocol” was adopted in the Second Conference of Parties to 
“The Convention on Biological Diversity”, held in Jakarta, Nov. 1995, in order to 
ensure the safety of development, application, exchange and transfer of biotechnology 
and its products (Liu and Xue, 1998a). 
 
3 3. Potential adverse impacts of modern biotechnology on socioeconomics 
Modern biotechnology may also have many unfavorable impacts on society and 
economic conditions as discussed below. 
 
3.1 Impacts on social and economic pattern 
Driven by perceived enormous economic profit, many famous international 
conglomerates have invested much capital in the R & D of biotechnology, and are 
altering step by step the world’s previous social and economic framework. For 
instance, Monsanto was traditionally a US-based chemical company.  Starting in 
1985, it began selling many of its core chemical factories, and invested in 
biotechnological industrials. Consequently,  Monsanto became a major conglomerate 
engaged in the R & D of bio-science (Enriquez
, 1998).  In 1998, about 20 million 
hectares of fields were planted with Monsanto’s genetically engineered seeds all over 
the world. To further exploit the international market for its crop seeds, Monsanto 
purchased the International Seeds Company of Cargill at the price of $140 millions in 
1998, for the purpose of making a completely integrated system for selling its own 
genetic engineering seeds (such as herbicide-resistanct transgenic soybean) and its 
agricultural chemicals (herbicides, for instance). Monsanto thus is able to control a 
large part of the complete food chain of human beings using its genetically engineered 
seeds to gain enormous profits. The world’s economy is becoming more integration 
and globalized.  It is possible in the future few multinational corporations may decide 
our food consumption.  Once toxic or allergic materials are found in the food chain 
engineered by them, it could be a catastrophe for the health of human beings. 
 
If bovine growth hormone (BGH) produced by genetic engineering are used in dairy, 
the milk yield of a dairy cow can increased by 30 percent and 10 per cent of its fodder 
saved at the same time. There will undoubtedly be major impacts on the dairy 
industry as a result (Liu and Xue, 1998b).  
 
In addition, many medicines, such as vaccines for treating malaria and cholera, will 
soon be delivered to patients in the form of new antigens synthesized within common 
fruits and vegetables bred by modern biotechnology. These foods will make the rates 
of illness and death in many countries (especially in the developing countries) fall 
precipitously, with the population growth rates increasing correspondingly. What will 
4 be the impacts on already inadequate economics and infrastructures of the concerned 
countries? Will it represent a benefit or a harm to our Earth burdened with huge 
populations (Miller,1998)? 
 
3.2  Impacts on biodiversity and sustainable agriculture 
Foreign genes from other plants, animals and microbes are contained within many 
genetic engineering crops. These foreign genes can be transferred to other plants in 
the nature via the pollens of genetically transformed plants.  This will pollute the pool 
of natural genetic resources. The damage to the environment and human society will 
be long-term, and the loss is incapable of being measured by money. Furthermore, 
because the majority of transgenic plants have desired traits such as high productivity, 
disease-pest resistance, stress resistance, farmers are attracted for economic interests, 
to grow these plants, rather than traditional crop varieties.  Therefore, natural 
biological species might be ignored or even discarded.  Consequently, the traditional 
crop varieties and natural biological species are likely to be lost and the genetic 
resource-base narrowed.  Furthermore, some technology by encouraging the 
monoculture of crop varieties in certain areas may further add to loss of biodiversity.  
In the long term, this erosion of the genetic base may undermine the resistance of 
plants to diseases and insect pests and this may result in reduced crop yields.  Hence, 
global sustainable development could be put in jeopardy. 
 
For another example, attracted by high financial returns over the last few years, an 
unprecedented numbers of farmers in one region of Andhra Pradesh state of India 
turned to plant a single hybrid cotton seed.  Due to the combination of unfortunate 
weather patterns and a pest outbreaks in one year, the crops of these farmers failed. 
Farmers, who had borrowed heavily to lease additional land and purchase pesticides, 
faced unmanageable debts, and over 70 debt-ridden farmers committed suicide. There 
is now a debate as to whether the imminent commercial release of Bt (Bacillus 
thuringiensis) cotton in India will avert or exacerbate such problems in the future 
(Crompton and Wakeford, 1998). 
 
Transgenic herbicide and pest resistant crops, produced by genetic engineering 
technology, are being planted in many countries on a large scale. The herbicide 
resistant genes in transgenic crops, however, can be transferred to other crops and 
5 their wild weedy relatives, and so result in new weeds and “superweeds” and the need 
for more herbicide use.  Consequently, environmental pollution may become worse, 
and use of herbicides less effective (Holden, 1990).  Bt (Bacillus thuringiensis) is a 
soil bacterium which is employed to produce an insecticidial toxin within plants.  It 
has been used as a microbial pesticide for many years. The genes coding insecticidal 
toxins could be transferred to many crops such as cotton, soybean, and rape, to breed 
pest-resistance crops. But the environmentalists and the Green Peace Corp are 
concerned that, because these crops produced these insecticidal toxins late in their life 
cycle, these BT transgenic crops planted on a large scale might increase the resistance 
of pests to the Bt toxins. This situation would result in greater use of BT-based 
pesticides and lead to a vicious resistance cycle, with Bt pesticides losing their 
efficacy and causing heavy economic losses. 
 
In September 1997, the US Environmental Protection Agency (EPA) was sued by a 
coalition of consumers, environmentalists, and organic farmers for allowing the 
planting of crops (corn, cotton, tomato) modified genetically to produce an 
insecticidal Bt toxin. The coalition demanded that EPA revoke 11 registrations which 
had issued to five companies, cease granting such permissions and complete a 
statement to analyze the environmental impact of Bt crops approved so far (Wadman, 
1997). They called for a prohibition on the introduction of transgenic herbicide-
resistance plants into forests and agricultural fields, and urged the UN Food and 
Agriculture Organization (FAO) to restrict the export of these plants to other 
countries. 
 
3.3 Impacts on socioeconomic welfare of countries and of communities 
Application of genetic engineering technology to humans could make it possible, to 
diagnose and cure genetically-related diseases such as some cancers and haemophilia, 
etc.. Gene diagnosis, however, may also have adverse impacts on the employment and 
marriage prospects of human beings.  For example, geneticists at Johns Hopkins 
University recently found that Ashkenazi Jews seemed to double the risk of colon 
cancer. Such findings have already led to Jewish groups being targeted as a potential 
market for commercial genetic tests, which might create the perception that Jewish 
people are unusually susceptible to disease. As a result, anyone with a Jewish-
sounding surname could face discrimination in insurance and employment. The 
6 Jewish leaders have been lobbying for laws to forbid genetic discrimination so as to 
avoid social stigmatization (Lehrman, 1997). 
 
Animals, plants and microbes can be transformed into bio-reactors by genetic 
engineering technology to produce particular kinds of chemical products as 
commended.  These obligate slave-like biological producers while increasing 
productive potential can give rise to socioeconomic problems.  Suppose a variety of 
yeast is engineered to produce vanilla in large scale. What kind of impact of this will 
have on the world’s major vanilla producers? In Madagascar, for instance, where 
vanilla accounts for 10 per cent of the country’s exports, what would be the effects on 
the nation’s agriculture, financial infrastructure? Who will be responsible for the 
influences (Miller, 1998). 
 
3.4 Impacts on traditional culture 
Some pious religious persons believe that because modern genetic technology 
changes, recodes and manipulates Nature that usurps the role of God.. For many gene 
manipulation involves an immoral (and unwarranted) intervention with God’s 
creation, with the natural order and evolution.  Especially concern has been expressed 
that gene diagnose (which was developed recently) might make descendant selection 
of human beings possible, and so disturb the evolutionary course of human beings. As 
a result, it is argued that modern biotechnology should be banned, forbidden or 
regulated as far as possible. For example, an organization in Europe call Mothers For 
Natural Law appealed for all genetically modified food be banned immediately, 
because genetic engineering is not some minor biotech development, but is a radical 
new technology that violates fundamental laws of nature (Golub, 1997). After the 
cloned sheep “Dolly” was born in 1997, the issue of “cloned man” has aroused strong 
reactions all over the world and had huge impacts on the present ethical and moral 
values. For instance, how do we decide on the relatives of a cloned man? Will human 
cloning lead to the creation of second-class citizens and even to a revival of slavery 
(Shapiro, 1997)? 
 
Members of the public have not been silent about  ethical and moral issues involved 
in the granting patents on modern biotechnologies and related property rights.  To 
encourage investing in the R & D of biotechnology, the patent regulations in some 
7 countries stipulated that varieties of animal, plant and microbe and their genetic 
materials and products, as well as production approaches are protected by patent. 
Since the early 1980s, for example, the United States PTO (Patent and Trademark 
Office) had awarded hundreds of patents for genetically engineered plants and 
recombinant DNA approaches to manipulate plants (Stone, 1995a). Most Christians 
believe that humans and other beings are created by God.  Some have argued that 
granting patents on genes or organisms represents the usurpation of the ownership 
rights of the Sovereign of the universe. So patenting of genetically engineered animals 
and human genes, cells, and organs is ethically unacceptable to them (Stone, 1995b).  
 
In addition, to fully protecting the interests of the biotechnological inventors, some 
countries often approved patent applications much wider breadth from hither to.  For 
example, in October 1992, the US/PTO (Patent and Trademark Office) awarded a 
patent to a single company, Agracetus, for the rights to all forms of genetically 
engineered cotton---no matter what techniques or genes were used to create them.; In 
March 1994, the European Patent Office (EPO) granted broad rights to Agracetus for 
all forms of genetically engineered soybean that produced foreign substances. The 
Roslin Institute of England also applied for the international patent for the cloned 
sheep “Dolly”, and requested that the protected breadth be mammals, include human 
being. The patent was made known to the public in March 1997 and aroused a panic 
internationally. These patents with such broad application not only could force smaller 
companies out of biotechnological business, but also might reduce the 
biotechnological research activities in certain countries and fields (Stone, 1995a). The 
width of these patent rights granted has the capacity to create mega-monopolies  
 
The patent system can also be used by some countries/individuals to usurp intellectual 
ownership of “native technologies”. For instance, the neem tree, known as the 
“blessed tree”, had been used by Indian farmers as a medicine for centuries. After 
conducting research on the tree’s properties, however, a US company patented a 
method of extracting and stabilizing azadirachtin, a potent natural pesticide, from the 
neem tree. The patent could hurt Indian farmers because they could be forced to stop 
using the technology which they have been using for generations or pay royalties for 
its use (Wolfgang, 1995). 
   
8 4. International concerns about biosafety and related socioeconomic issues of 
biotechnology 
Many countries are taking socioeconomic issues arising from new biotechnology very 
seriously. For example, some member countries of the EU (Austria, Denmark, 
Sweden, and Finland) believe that the socioeconomic impacts should be specifically 
taken into account when drawing up biosafety regulations. The Norwegian Gene 
Technology Act required that, before deciding whether or not to grant a license or 
patent application, significant emphasis should be placed on whether the deliberate 
release of Living Modified Organisms (LMOs) represents a benefit to the community 
and a contribution to sustainable development (Crompton, 1998). 
 
The UNEP’s “International Technical Guidelines for Safety in Biotechnology” also 
draws attention to the importance of assessing the socioeconomic impacts of 
biotechnology. During the negotiation of the “International Biosafety Protocol”, 
socioeconomic impacts was one of areas given special attention by several 
participating countries. 
 
In general, developed countries possess a high level of biotechnological expertise, 
with greater ability to solve biosafety issues than developing countries. They are the 
exporters and beneficiaries of biotechnological products.  Many developed countries 
involved in negotiations argued that the socioeconomic issues of biotechnologic 
change were too complex for them to contribute constructivity to the debate because 
of their relative ignorance, although the issues were important. They agreed there was 
an urgent need for socioeconomic issues to be studied exhaustively.  It was agreed that 
it is appropriate for international biosafety legislation to take such issues into 
consideration, and the socioeconomic issues of biotechnology should be discussed 
alone in another global forum.  
 
In contrast to developed countries, developing countries have low biotechnological 
capacities, with little ability to solve biosafety issues. They are the importers of 
biotechnology and potential victims of the adverse impacts of biotechnological 
products. As a result, some developing countries, such as India and China, believe that 
socioeconomic issues raised by modern biotechnology were very important to all 
countries, especially for the developing countries endowed with rich genetic 
9 biodiversity. They insisted that socioeconomic issues taken into account as an 
essential part of international biosafety legislation, that public safety should be 
protected through suitable policies and regulations. In addition, measures should be 
taken to ensure that economic activity and the distribution of income are economic 
opportunities and are not impaired by monopolization of biotechnologies, and it is 
needed to control production of genetic material such as seeds and associated 
chemical and biological substances by some private enterprises. They also requested 
that the Contracting Parties to The Convention on Biological Diversity who planned 
to produce with biotechnology a commodity that had been previously imported, 
should notify in advance the other Parties whose exports would be reduced. The 
notification should be made sufficiently in advance (at least seven years), to enable 
the latter to make alternative production plans. When the affected Parties are 
developing countries, the Parties that replaced the imported products by 
biotechnological products should provide the affected Parties with financial and 
technical aid (Liu and Xue, 1998c).
 
 
Thus it can be seen that, not only can biotechnology produce enormous social and 
economic benefits, but it may also result in many serious socioeconomic problems. 
Those problems are intensified because of the vastly different stages of 
biotechnological development developed and less developed countries and regions 
and because of the varied economic and political situation of many countries and 
regions. Biotechnology policies need to accommodate those differences.  Because of 
divergent development and social status of countries, it will be difficult to obtain 
global consensus in the short term on biotechnology policies and the socioeconomic 
issues which should be taken into account in such policies.  It is possible that 
international disputation about biotechnology policies will continue for a long time.  
Nevertheless if now biotechnology is to contribute the sustainable development of the 
world, international society must make concerted efforts via policy formulation to 
address the possible detrimental socioeconomic impacts of biotechnology, some of 
which have been highlighted in this contribution.  
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